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Pertussis toxin, PT, abolishes inhibitory regulation of adenylate cyclase by cell surface receptors. Inhibitors 
of adenylate cyclase in GH, cells, namely somatostatin a d the muscarinic cholinergic agonist carbachol, 
lower the cytosolic free Ca2+ concentration. [Ca2+], and cause hyperpolarization. These responses are selec- 
tively abolished by PT. It is concluded that the effects of somatostatin a d carbachol to lower [Ca’+]i and 
to hyperpolarize are secondary to their inhibitory action on adenylate cyclase. In contrast, PT does not im- 
pair the TRH induced rise in [Ca’+]i in GH, cells demonstrating that the coupling of TRH receptors to 
Ca2+ mobilization isnot mediated by a P’I’ substrate. 
Pertussis toxin Cytosolic Ca2+ Somatostatin 
1. INTRODUCTION 
Regulation of adenylate cyclase activity by 
stimulatory or inhibitory receptors is mediated by 
the GTP-regulatory proteins N, and Ni [1,2]. N, 
and Ni are substrates for the GDP ribosylation 
reaction catalysed by the A subunits of cholera 
toxin and PT, respectively, a toxin isolated from 
the culture medium of Bordetefla pert&&s [3]. PT 
selectively impairs inhibitor regulation of 
adenylate cyclase [4] by the ADP ribosylation of a 
41 kDa protein, the cr subunit of Ni [5,6]. 
We have shown previously that inhibitors of 
adenylate cyclase such as somatostatin and car- 
Abbreviations: N,, Ni, the guanyl nucleotide regulatory 
units which mediate hormonti stimulation (N,) or inhibi- 
tion (Ni) of adenylate cyclase; PT, pertussis toxin; 
[Ca2+]i, cytosolic free Ca” concentration; fMLP, N- 
formyl-Met-Leu-Phe; IP3, myo-inositol 1,4,5trisphos- 
phate; PIP2, phosphatidylinositol 4,5-his-phosphate; 
TRH, th~otropin releasing hormone; bis-oxonol, 
bis( 1,3-diethylthiobarbiturate)t~methin~xonol; VIP, 
vasoactive intestinal polypeptide 
Muscarinic cholinergie agonist TRH Pitziitary 
bachol, a muscarinic cholinergic agonist, lower the 
[Ca2’]i and cause hyperpolarization of GH3 cells 
[7,8], a cell line derived from rat pituitary tumors 
[9]. In this study we use PT to probe for the in- 
volvement of Ni [4] in mediation of the effects of 
somatostatin and carbachol on [Ca2+]i and mem- 
brane potential. 
Recent reports have shown that PT abolishes the 
action of the chemotactic peptide fMLP in ac- 
tivating neutroph~s, inhibiting the hydrolysis of 
PIP2 [lo,1 11, the generation of IPs 112,131 and the 
transient rise in [Ca”]i [ 13,141. It was concluded 
that a PT substrate is involved in receptor stimula- 
tion of phospholipase C and possibly the subse- 
quent mobilization of Ca”. 
Likewise, it has been reported that GTP 
analogues can enhance diacylglycerol formation in 
leaky platelets [15] and stimulate phospholipase C 
in cell free systems [11,16,17]. Taken together 
these findings suggest hat a GTP binding protein 
similar or identical to Ni is involved in the coupling 
of receptors to enhanced PIP2 breakdown. We and 
others have shown that TRH, similar to fMLP in 
neutrophils, acts in GH3 cells to enhance PIP2 
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hydraiysis by phospholipase C, generating IFS 
]18-21] which in turn mubilizes Ca2+ from in- 
tracellular stores [22,23]_ A further aim of this 
study was therefore to investigate whether FT 
would affect he Ca” mobilizing action of TRH in 
GH3 cells. 
2. MATERIALS AND METHODS 
GHJ cells obtained from the American type 
culture collection were maintained in monolayer 
culture as described [lo]. Prior to the experiments 
they were incubated for 16 h with PT, 30 ng/ml, 
added to the culture medium. The cells were then 
detached from their substrate, left in a suspension 
culture for l-3 h and loaded with quin2 as de- 
CONTROL 
1L - 2 min atr 
scribed (241. PT, 30 nglml, was present during the 
suspension culture period. [Ca’+]i was determined 
frum q&n2 fluorescence [Zs] and the average 
membrane potential was monitored with the 
fluorescent probe bis-oxonot ]26] as described 
]7,24]. Statistical nalysis of the data in table 1 was 
performed by analysis of variance foilowed by an 
a posteriori test (DUNCAN test). Single ex- 
periments hown represent at least 3 repetitions 
performed on different batches of cells. PT was 
obtained from List Biological Laboratories, 
Campbell California. For a preliminary experi- 
ment PT was kindly provided by Dr R.G. Larkins. 
Bis-oxonoi was a gift from Dr R. Tsien, quin2 
acetoxy methyl ester was from Sigma or Amers- 
ham, carbachol (~bamoy~~hu~ine chloride) and 
PT 
[ I Ca”* i JIM 
carb 
F i 
T i K+ 1
0”” , atr 2 min , K* - _ 2 min a 
Fig. 1 a PT abolishes the effects of carbachol (carb) and of somatostatin (soma) on [Ca”]; and on the average membrane 
potential of CH3 cells. (A) Quin2 fluorescence traces calibrated for [Ca2’]i in cells (2 x lo6 per ml) exposed to PT 
(JO ng/ml) or control cells from the same batch; arrows denote the time of addition of carbachol (carb), atropine (atr), 
somatostatin (soma) and KC1 (K’) to the final concentrations of lO/cM, f PM, 0.1 FM and 54 mM, respectively. (3) 
Fluorescence of bii-oxonol, 50 nM (expressed in arbitrary units), monitoring &he average membrane potential of GH3 
cells (5 x 10s per ml), expose.d to F@T or control cells from the same batch, under conditions identical to those in the 
experiment shown in panel A. 
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atropine (a&opine s~phate~ were from Fluka, 
somatostatin from Clin. Midi Corp. or CRB, and 
other materials from sources described in f7,24]. 
3, RESULTS 
[Ca”]i is lowered in GH3 cells in response to 
carbachol [8] and somatostatin [7]. The [Ca2’]i 
response to these inhibitors of adenylate cyclase 
can be demonstrated in a single experiment, as is 
shown in fig.lA_ After the addition of carbachol, 
[Ca2”]i s lowered from a basal level averaging 
116 nM (table 1) to about 70 nM, A&opine, an in- 
hibitor of the muscarinic acetylcholine receptor, 
reverses the action of carbachol such that {Ca**]i 
returns within 2 min to the original basal levels. 
The subsequent addition of somatostatin causes a
rapid and marked lowering of [Ca”Ji and upon 
depolarization with K+ [Ca2’]i rises immediately to
a level of about 500 nM. Performing an identical 
experiment on the same batch of cells after ex- 
posure to 30 ngfml PT for 16 h, the inhibitory 
responses to both carbachol and somatostatin are 
no Ionger observed, whereas there is a similar rise 
in [Ca%]i following de~Iari~tion with K+. The 
PT effect to abolish inhibitory regulation of 
[Caz*]i s maximal at the dose of 30 rig/ml. A par- 
tial loss of somatostatin and carbachol effects can 
be observed already at 3 ng/ml PT, whereas ex- 
periments performed with 300 ng/ml PT give 
similar results to those observed with 30 ng/ml 
(riot shown). 
Fig. 1B shows that upon PT treatment the effects 
of sornatostatin and carbachol on the average 
membrane potential are lust concomitantly with 
the effects on [Ca**]i. In an experiment performed 
identically to that described in fig. 1A on both con- 
trol and PT treated cells, the monitoring of 
fluorescence by the membrane potential probe bis- 
oxonol reveals that the hyperpolarization by ear- 
bachol, its reversal by atropine and the hyper- 
polarization by somatostatin are completely 
abolished by the toxin, however the enhancement 
of fluorescence by K* reflects that its depolarizing 
effect on GH3 cells is unaltered by PT. 
The selectivity of the PT effect can be ap- 
preciated from the data presented in fig.2 and table 
1. VIP, a stimulator of adenylate cyclase, causes a
transient rise of [Ca2+]i in both control and PT 
treated cells. In the same experiment PT causes a 
complete loss of the action of somatostatin and 
carbachol to lower [Ca2’]i. The peak [Ca2+]i 
values reached in GH3 cells after stimulation by 
VIP are not si~ificantly different in toxin treated 
vs control cells (table I). It should be noted that the 
kinetics of the [Ca’+]i response to a maximal dose 
of VIP remains unaltered by PT. 
Similar to the [Ca’+]i response to VIP, the rise 
in [Cazs]i due to TRH remains unaltered by PT. 
As can be seen in fig.2B, control cells respond to 
somatostatin and TRH by lowering and raising 
[Ca’+]i, respectively. In PT treated cells the 
somatostatin effect is completely abolished 
whereas following TRH there is a rapid and tran- 
Table 1 
fCa’“]i in G& cells: the effect of PT on hormonal responses 
Control PT Difference 
nM f SE (n) nM f SE (n) PT vs control 
Basal 116 f 3 (45) 111 f 3 (17) n.s. 
Carbachol, 100 /rM 68 + 3 (15) 120 * 5 ( 5) p < 0.01 
Somatostatin, 0.1 ,uM 78zk 5(9) lOOk 4(7) p < 0.05 
TRH, 0.1 pM 276 f 37 (13) 253 f 37 ( 7) lL.5. 
VIP, 0.1 @I 213 f 25 ( 5) 164 ztz 12 ( 4) ll.S. 
n.s,, not significant; G& cells were exposed to PT, 30 ngr’ml, for 16 h. 
Steady state [Ca”]i in the presence or absence of carbachol or somatostatin 
and peak values for the transient elevation in [Ca*+fi following stimulation 
by TRH or VIP were determined from q&n2 fluorescence as described 
[8,9,26]. Results are expressed in nM as the mean f SE (?z = number of 
experiments) 
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Fig.2. Regulation of [Ca2+]r in GH cells by VIP, somatostatin (soma), carbachol (carb) and TRH: selective effects of 
PT. Quin2 fluorescence traces calibrated for [Ca2+]i in cells (2 x lo6 per ml) exposed to PT (30 ng/ml) or control cells 
from the same batch; arrows denote the time of addition of 0.1 M VIP (final concentration), 0.1 M somatostatin 
(soma), 0.1 mM carbachol (carb), 0.1 M TRH, and 54 nM KC1 (K+). Traces in panels A and B were monitored at a 
free extracellular [Ca2’] of 1 mM; traces in panel C were observed in Ca2+ -free medium containing 1 mM EGTA, i.e. 
at a free extracellular [Ca2’] lower than 100 nM. 
sient rise in [Ca2+]i, and the PT exposed cells main- 
tain a steady state [Ca2+]i above baseline as has 
been described for control cells [24]. The peak 
value reached after TRH stimulation averages 
253 nM in PT treated cells, not unlike the average 
value of 276 nM observed in control cells (table 1). 
Submaximal concentrations of TRH elicit a similar 
rise in [Ca’+]i in PT treated vs contol cells (not 
shown) and hence PT does not appear to alter 
TRH sensitivity. Fig.2C shows that TRH acts 
equally well in GH3 cells exposed to PT as in con- 
trol cells to raise [Ca’+]i transiently at very low ex- 
tracellular free [Ca2+]i by mobilizing Ca2+ from an 
intracellular pool [24]. 
30 
Table 1 summarizes the effects of PT on the 
regulation of [Ca2+]i in GH3 cells. There is a 
significant change due to PT in the average steady 
state [Ca2+]i observed in the presence of either 
somatostatin or carbachol. In contrast, neither the 
average basal [Ca2’]i nor the peak values of 
[Ca’+]i after stimulation by either VIP or TRH are 
significantly altered. 
4. DISCUSSION 
There are 2 major aspects of the data presented 
above: PT treatment of GH3 cells completely 
abolishes the effects of somatostatin and carbachol 
VoIume 189, number I FEBS LETTERS September 1985 
to bower ~ca*‘ji and to cause b~erpola~ation~ 
PT exposed GHfls cells respond however normally 
to several stimulaturs of PRL secretion, in par- 
ticular to TRH which acts via accelerated PIP; 
hydrolysis to mobilize Ca2+. 
There is now increasing evidence that GTP 
binding proteins are involved in the receptor 
mediated acceleration of phosphoinositide turn- 
over and Ca*+ mobilization [lO-171. From the 
observation that PT blocks the stimulation of 
ne~~ophils by fMLP flO-141, mediated by 
enhanced PfPt breakduwn~ it appears that the N 
protein finking receptors to the acceleration of 
phos~hoinositide turnover is a PT substrate similar 
or identical to Ni. The data presented above show 
that such a conclusion should at present not be 
generalized: TRH action to mobilize Ca’+, 
mediated like the effects of fMLP on neutrophils 
by enhanced PIP2 hydrolysis, is unaffected by PT. 
Similarly, it has been reported that muscarinic 
receptor mediated phosphoinositide hydrolysis and 
Ca2* mobilization are not inhibited by PT [27j. A 
str~ghtforward hypothesis to account for the dif- 
fer~~ti~ sensiti~ty to PT treatment would propose 
that - in analogy to the adenyla~e cyclase system 
which contains Ns and Ni - similar but not iden- 
tical N proteins couple the various receptors to the 
phospholipase C reaction, only part of them being 
PT substrates. Irrespective of the reasons for the 
lack of a PT effect on the response to TRH, it 
should be emphasized that PT cannot be generally 
used as a probe to investigate receptor coupling to 
enhcanced PIP2 hydrolysis. 
There is evidence that PT abolishes the inhibi- 
tion of adenylate cyclase by s~m~tostatin and 
do~~i~e in pituita~ cells l[as,29] and of 
muscari~ic agonists in Gl& cells [JOI in which it 
causes ADP ribosyfation of a 41 kDa protein, 
presumably Ni {31]. In GW3 cells alterations in 
adenylate cyclase activity are paralleled by changes 
in [Ca’“‘]i and the average membrane patential, 
Stimulation of adenylate cyclase by VIP or for- 
skolin raise [Ca2’]i [32], the inhibitors carbachol 
and somatostatin lower [Ca2+Ji and cause hyper- 
~~l~r~zatio~l. Since PT completely abolishes these 
effects of somatostatin and carbachol we conclude 
that their primary action is exerted on adenylate 
cyclase, and that the lowered [Ca’*l;i and the 
h~~rpolar~ation are a consequence of reduced 
CAMP production. fn regard to the mechanism of 
such regulation, it appears that changes in steady 
state fCa2”]i must result from altered Ca2+ fluxes- 
Since in GHs cells steady state {Caz+ji s largely 
dependent on Ca2+ influx via the voltage- 
dependent Ca”-channel [24], reduced steady state 
[Ca2*]i observed in the presence of somatostatin or 
carbachol most probably reflects reduced Ca” in- 
flux. PhosphoryIation by CAMP-dependent pro- 
tein kinase enhances the conductivity of the 
voltage-dependent Ca*+-channel, whereas it 
decreases Qoltag~ependent K+ currents preview 
f33,34& inhibitors of adenylate cyczase thus could 
lead to a reduction of the proportion of 
phosphor~ated Ca”- and Kf-channels, decreased 
Cat* conductance leading to the lowering of 
[Ca2*]i and concomitantly increased K’ currents 
resulting in hyperpolarization. 
It has been reported that PT can impair in- 
hibitory regulation of pituitary hormone secretion 
by somatostatin [ZS] and dopamine [29] in rat 
anterior pituitary cells in primary culture and by 
muscarinic cholinergic agonists in GHJ cells 
f30,31]. inhibition of adenylate cyclase by these 
ligauds, mediated by the PT substrate Ni, leads to 
reduced st~~lat~on of CAMP levels due to 
stimulators of secretion, an action which was lost 
also upon PT treatment !28-301. These firxdiags 
suggest hat reduced pituitary hormone secretion 
in the presence of somatostatin, dopamine and 
muscatinic choliuergic agonists results from re- 
duced CAMP levels. The reports that dopamine 
[35], somatostatin [7] and carbachol [g], the latter 
acting through muscarinic acetylcholine receptors, 
lower [C&]i in pituitary cells points to an alter- 
native ~ssib~lity of how these Iigands cuuld act to 
inhibit s~retio~: all 3 inhibitors reduce basal 
fCa2’]; and appear to attenuate the nosiest rise in 
fCa”]i provoked by stimulators of secretion 
f8,35]. The concomitant loss of the inhibition of 
secretion, of the lowering of [Ca”];, and of the in- 
hibition of adenylate cyclase following PT treat- 
ment is consistent with a role for the lowering of 
[Ca2’]i - as a consequence of reduced CAMP pro- 
duction - in the mediation of inhibitory regulation 
of pituitary hormone secretion. 
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